TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
University of Connecticut researchers reported that mice repeatedly given cannabinol (CBN) developed tolerance and withdrawal-like physical signs. The study does not establish that CBN causes dependence in people, and its effects at typical supplement doses and with long-term use remain unclear.
Researchers at the University of Connecticut found that mice given cannabinol (CBN) repeatedly developed tolerance and physical signs resembling withdrawal, raising safety questions about a cannabis compound increasingly marketed in sleep products. The experiments do not show that CBN causes dependence in people, and researchers say its risks with regular human use are not yet known.
In the study, mice received CBN twice a day for three consecutive days. As treatment continued, they became less responsive to the compound, which the researchers interpreted as tolerance. After CBN was withdrawn, the animals showed movements including head twitching and paw fluttering, described in the report as withdrawal-like signs. The findings were published in the November issue of the journal Drug and Alcohol Dependence.
In a separate experiment, mice trained to recognize THC’s psychoactive effects responded similarly when given CBN. The researchers said this points to overlapping effects in mice; it does not establish that people experience CBN as they experience THC. The results suggest CBN can affect some of the same biological systems associated with THC, despite being generally regarded as less psychoactive.
The team also reported anti-inflammatory effects, including at lower doses that did not produce psychoactive effects. But in a simulated bacterial challenge, CBN reduced the animals’ ability to defend against infection. These findings are also from animal experiments and do not establish the effects of CBN on human immunity or its potential benefits in people.
Risks for Regular CBN Users
The findings matter because CBN appears in gummies, tinctures and capsules promoted as sleep aids, while evidence about repeated use and long-term effects remains limited. A product marketed as a gentle or natural way to sleep may still have biological effects that have not been well characterized. The mouse results do not prove harm to consumers, but they identify questions that need human research.
For people considering these products, the main practical point is not that the study establishes CBN is addictive; it does not. Rather, researchers have seen tolerance and withdrawal-like signs in mice and say it is uncertain whether comparable effects occur in humans, especially with frequent use or higher doses. The findings also make it harder to assess product claims about sleep when the compound’s effects on sleep quality and appropriate dosing have not been established by the evidence described in the report.
The study’s anti-inflammatory result points to possible research uses, while the bacterial-challenge finding adds a separate safety question. Taken together, the results do not settle whether CBN has a useful role in treatment. They underline the need to study benefits, doses and potential harms together before drawing conclusions about regular use.
Products Worth Considering
Fitbit Sense Health & Fitness Smartwatch (White/Gold, International Version)
Coway Mighty AP-1512HH(W) Air Purifier, White
Fitbit Versa 2 Health and Fitness Smartwatch with Heart Rate, Alexa, Music, Sleep and Swim Tracking
As an affiliate, we earn on qualifying purchases.
CBN’s Place in Cannabis Products
CBN is a naturally occurring cannabis compound, alongside THC and CBD. It is generally considered less psychoactive than THC and has gained visibility as manufacturers promote minor cannabinoids for sleep and other claimed benefits. The researchers said that wide-ranging therapeutic marketing has outpaced knowledge about potential risks, particularly with repeated exposure.
The report describes a familiar challenge in evaluating products marketed for sleep: a compound’s popularity and its presence in consumer supplements do not by themselves establish that it improves sleep or is safe for long-term use. The UConn study focused on mice and on responses to CBN, not on a clinical trial of people taking commercially available gummies. It therefore cannot determine how the study’s dosing compares with amounts in a particular product.
Researchers also pointed to the history of sleep treatments that were initially promoted as helpful but later found to carry dependence risks. That history is a reason for scrutiny, not evidence that CBN will have the same outcome. The present findings offer an early animal signal, rather than a human assessment of safety or effectiveness.
“Our findings suggest consumers should be aware repeated use may carry risks.”
— Steven Kinsey, professor in UConn’s Elisabeth DeLuca School of Nursing
Human Effects Remain Unknown
The study does not establish whether CBN causes dependence or withdrawal in people. The experiments were conducted in mice, and the report says researchers do not yet know how CBN affects human sleep quality or whether repeated use at doses commonly found in supplements could lead to addiction. It is also unclear how the experimental doses relate to products consumers buy.
The immune finding came from a simulated bacterial challenge in mice, so its relevance to people is unconfirmed. The report does not provide evidence that users of CBN products face a particular infection risk. More human research is needed to evaluate potential effects, including with frequent use, higher doses and extended exposure.
Further Studies Needed
The researchers say additional studies are needed to determine how CBN affects people, including whether the animal findings appear with human use and how dose and duration influence its effects. Human research would also need to assess whether CBN improves sleep, what side effects may occur and whether repeated use changes its effects over time.
Until that evidence is available, the study cannot confirm that CBN sleep products cause dependence in consumers or establish a safe long-term dose. The next evidence needed is research that directly addresses human safety and effectiveness, rather than relying on animal results or marketing claims.
Key Questions
Does this study prove CBN is addictive for people?
No. The study found tolerance and withdrawal-like signs in mice. It does not establish that CBN causes dependence in humans.
What did the mice experience after CBN was withdrawn?
After repeated dosing, mice showed physical movements including head twitching and paw fluttering. Researchers described these as signs resembling withdrawal.
Does the research show that CBN improves sleep?
No. The reported experiments do not establish whether CBN improves sleep quality in people. The researchers said that question remains unanswered.
Did the study find any potential benefit from CBN?
Researchers reported anti-inflammatory effects in mice, including at lower doses without psychoactive effects. The animal result does not establish a medical benefit for people.
What research is still needed?
Further studies must assess human effects, dosing and long-term use, including whether CBN affects sleep and whether repeated exposure carries risks comparable to those seen in the animal experiments.
Source: rss
